For Doctors Archives - GastroNorth

NEW ONLINE TOOLS

Online CRC Screening & Surveillance Decision-Support Tools GPs play a crucial role in colorectal cancer prevention, but CRC screening and surveillance guidelines are often complex, detailed, and difficult to recall during a busy consultation. Family history recommendations are often misunderstood, while post-polypectomy surveillance intervals require consideration of multiple factors and findings across previous colonoscopies. These […] Read more...

MANAGING CHRONIC CONSTIPATION

My patient has tried Movicol, fibre and stimulant laxatives. What’s next? Chronic constipation is a very common presentation in general practice. First line therapy typically includes dietary...

WHEN TO WORRY ABOUT BLOATING

Bloating, a benign nuisance or a red flag? Bloating and abdominal distension are common in general practice and are often functional. They are frequently associated with under-recognised...

H.PYLORI NOT SUCCESSFULLY ERADICATED? WHAT TO DO NEXT.

Helicobacter pylori (H.Pylori) eradication reduces the risk of peptic ulcer recurrence, gastric cancer, and persistent dyspepsia. In Australia, the most commonly used first-line regimen...

WEGOVY IN MASLD/MASH

What you need to know. Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as NAFLD, is now the most common chronic liver condition worldwide. It is strongly associated...

MANAGEMENT OF MASLD

Metabolic dysfunction-associated steatotic liver disease (MASLD) or Metabolic-associated fatty liver disease (MAFLD), has become the most common chronic liver disease, and its prevalence will likely...

INTESTINAL ULTRASOUND – USEFUL?

Intestinal ultrasound (IUS) is an accurate and non-invasive tool to assess disease activity in inflammatory bowel disease (IBD). IUS is now increasingly used in Australia as a method to monitor...

HEPATITIS C – WHO SHOULD BE TESTED & WHY

The following groups should be considered for hepatitis C testing: Testing and early diagnosis are vital because hepatitis C often remains asymptomatic until advanced liver disease develops. Early...

BOWEL CANCER SCREENING IN INDIVIDUALS WITH A FAMILY HISTORY – Updated Clinical Guidelines

In October 2023, updates were made to the NHMRC-endorsed clinical guidelines regarding bowel cancer screening. These revisions aim to enhance the effectiveness of screening strategies and improve...